@Full-Oncology

Full-Oncology is a relatively active trader on Polymarket, having completed 900 trades across 130 markets over 70 days. Despite the considerable trading volume of nearly $1.9 million, their net profit and loss stands at a negative $1,159.44, placing them at rank #2,616,711 on the global PnL leaderboard. With a Smart Score of 19 out of 100, Full-Oncology is classified as a beginner trader, and their portfolio value currently reads zero, indicating possible liquidation or withdrawal of funds.

The trading style of Full-Oncology suggests a high-risk, high-frequency approach, as evidenced by their 36.9% win rate and a minimal profit factor of 1.04. They show a preference for a broad set of markets but avoid weather-related markets, with only 10% of trades involving selling positions. The trader’s contrarian and diamond hands badges imply a tendency to hold positions longer and to bet against prevailing market sentiment, which aligns with their high roller and whale status, indicating large trade sizes. However, their Sharpe ratio of -0.01 and downward equity trend point to overall negative risk-adjusted returns.

Full-Oncology’s strengths lie in their willingness to engage across numerous markets and maintain large position sizes, potentially capitalizing on market inefficiencies. However, the low win rate and negative net PnL highlight significant risks, including poor timing or strategy execution. The lack of drawdown duration suggests no extended recovery periods, but the overall downward trend and beginner status indicate a need for strategy refinement to improve long-term performance on Polymarket.